Innovation and Regulation... Might Reason Prevail
| 1 Comment |

Kudos to Dr. Tom Stossel for his concise and insightful piece outlining some of the underlying absurdities reflected in recent legislation. In a Wall Street Journal op-ed cleverly titled, Who Paid for Your Doctor's Bagel?, he lays out what happens when ideology masquerades as conflict-of-interest. The point he brings forward is the total lack of value (and abuse of taxpayer and private sector resources) in the scrupulous reporting of 'gifts' to physicians worth more than $10.

At the heart of the legislation is an overreaction to examples of real fraud and abuse engaged in by unscrupulous physicians and industry players. Unfortunately, every industry and walk of life have their unscrupulous characters, including the Church, the media, the government, the pharmaceutical and medical device industries, and yes, medicine.

Some physicians did exercise poor judgment, did falsify data, did prescribe drugs they knew were medically inappropriate -- and some industry folks did engage in professionally unethical and illegal behavior when it came to off-label promotion. These people and their companies have been (and continue to be) punished for such behavior.

But to generalize to all industry-physician relationships and suggest that they are inherently evil, is just a bit over the top and throws the proverbial baby out with the bath water. The attitude reflected by many Congressional leaders is one that positions physicians as easily swayed by personal contact with pharmaceutical reps who peddle their wares.

The presumption that physicians are such weak characters would generally be insulting. But to step back and put it in context, it is an absurd and outrageous suggestion. These are the very same physicians that we entrust with our lives. How can they be capable on the one hand of making life-and-death decisions on our behalf and not be able to withstand the influence of a manufacturer's rep on the other?

As we continue to look for opportunities to facilitate needed innovation across the industry, collaboration between manufacturers and the practice community will be essential. Let's hope that reason will, once again, prevail.

1 Comment

Innovate and regulate appears to be the proof of progress for the simple fact that unregulated industry produces unnecessary risk that becomes the one step forward and two back that no industry can truly afford. Greater risk may produce greater profit, but it is a profit that no one wants to cultivate due to the high risk imposed upon those who may suffer inadvertently or become the target of such irresponsible capitalsim.

Predatory markets are everywhere, and can be anywhere, but at what price such profits through a capitalism that has no principles worthy of embracing?

God may have passed out brains, but logic isn't his domain. That is left to human interpretation, and allowing some to use them, and some not, or for personal advantage through predatory means isn't sufficient regulation of the human animal - in any country. It is inhumane, and becomes a heinous crime when it could have been avoided through regulation and oversight.


keep in touch     Follow Us on Twitter  Facebook  Facebook


Our Research

Rhetoric and Reality—The Obamacare Evaluation Project: Cost
by Paul Howard, Yevgeniy Feyman, March 2013


Warning: mysql_connect(): Unknown MySQL server host 'tmiweb52.vwh.net' (2) in /home/medicalp/public_html/incs/reports_home.php on line 17
Unknown MySQL server host 'tmiweb52.vwh.net' (2)
Archives

Blogroll

American Council on Science and Health
in the Pipeline
Drugwonks
Pharmalot
Reason – Peter Suderman
WSJ Health Blog
The Hill’s Healthwatch
Forbes ScienceBiz
The Apothecary
EyeOnFDA
KevinMD
Marginal Revolution
Megan McArdle
LifeSci VC
Critical Condition
EconLog
In Vivo Blog
PharmaGossip
Pharma Strategy Blog
Drug Discovery Opinion